OBJECTIVES: To test whether case-control-based familial aggregation studies produce estimates of risk to relatives that are inherently biased or confounded by age and family size, and to compare case-control-derived estimates with those from the reconstructed cohort method. In addition, we test if the definition of family history affects the accuracy of results obtained from either design. We use simulated data, which allows us to know the true data origin. METHODS: We simulated populations of three generation families. Both a dominant genetic disease and a non-genetic disease were present in the population. We compared the effect estimates from different measures of family history with those derived from the actual genetic cause of disease. RESULTS: Effect estimates from family history measures that used multiple family members were more accurate than those derived from measures based on a single relative. Neither family size nor age of family members defining family history were confounders in the case-control design. CONCLUSION: The case-control and reconstructed cohort designs are equally valid in assessing familial aggregation of disease. Copyright 2009 S. Karger AG, Basel.
OBJECTIVES: To test whether case-control-based familial aggregation studies produce estimates of risk to relatives that are inherently biased or confounded by age and family size, and to compare case-control-derived estimates with those from the reconstructed cohort method. In addition, we test if the definition of family history affects the accuracy of results obtained from either design. We use simulated data, which allows us to know the true data origin. METHODS: We simulated populations of three generation families. Both a dominant genetic disease and a non-genetic disease were present in the population. We compared the effect estimates from different measures of family history with those derived from the actual genetic cause of disease. RESULTS: Effect estimates from family history measures that used multiple family members were more accurate than those derived from measures based on a single relative. Neither family size nor age of family members defining family history were confounders in the case-control design. CONCLUSION: The case-control and reconstructed cohort designs are equally valid in assessing familial aggregation of disease. Copyright 2009 S. Karger AG, Basel.
Authors: Laura Baglietto; Mark A Jenkins; Gianluca Severi; Graham G Giles; D Timothy Bishop; Peter Boyle; John L Hopper Journal: J Clin Epidemiol Date: 2006-02 Impact factor: 6.437
Authors: Amy M Linabery; Erik B Erhardt; Michaela R Richardson; Richard F Ambinder; Debra L Friedman; Sally L Glaser; Alain Monnereau; Logan G Spector; Julie A Ross; Seymour Grufferman Journal: Int J Cancer Date: 2015-05-19 Impact factor: 7.396